ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,184, issued on May 26, was assigned to Alcon Inc. (Fribourg, Switzerland).
"Schlemm's canal drug eluting device and method" was invented by Brett A. Trauthen (Newport Beach, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of delivering a pharmaceutical composition to Schlemm's canal of an eye is disclosed. The method may comprise inserting a drug delivery device in conjunction with a microstent into Schlemm's canal. The drug delivery device may comprise a bioerodable polymer and a pharmaceutical composition, and the drug delivery device may be configured to erode over time and to elute the pharmaceutical composition into aqueous humor ...